Chidamide tablets: HDAC inhibition to treat lymphoma

Xu, Y; Zhang, P; Liu, Y

Liu, Y (reprint author), Zhengzhou Univ, Dept Internal Med, Henan Canc Hosp, 127 Dong Ming Rd, Zhengzhou 450008, Peoples R China.; Liu, Y (reprint author), Zhengzhou Univ, Affiliated Canc Hosp, 127 Dong Ming Rd, Zhengzhou 450008, Peoples R China.

DRUGS OF TODAY, 2017; 53 (3): 167

Abstract

Chidamide is the first oral subtype-selective histone deacetylase inhibitor (HDACI) approved in China as well as the first HDACI of the benzamide clas......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索